| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3981380 | Clinical Radiology | 2016 | 7 Pages |
Abstract
CE-TRUS exhibited greater diagnostic accuracy for diffuse prostate cancer than baseline TRUS. CE-TRUS may improve cancer detection over baseline TRUS imaging for the diagnosis of diffuse prostate cancer in patients with an elevated PSA level. CE-TRUS detects diffuse prostate cancer without an obvious focal mass on routine TRUS or clinical examination, and therefore, may help identify patients who do not need a repeat biopsy or who do not need to undergo systematic 12-core invasive sampling biopsies.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Y. Gao, X.H. Liao, L. Lu, L. Wang, Y. Ma, H.Z. Qin, X. Yan, P. Guo,